Cardiovascular Risks Are High in Young Adults with End-Stage Renal Disease

But early nephrology care is associated with reduced risks for CVD hospitalization and mortality.

Cardiovascular disease (CVD) is the chief cause of death for patients with end-stage renal disease (ESRD), but how ESRD affects CV risk among young adults, in particular, is not known. To understand the impact of young-adult–onset ESRD, researchers obtained data from the U.S. Renal Data System for a population-based cohort study among 33,156 young patients, who had ESRD care initiated at different ages.

Five-year CVD mortality rates were 7.3% in young-adulthood–onset ESRD (onset at ages 22–29), 4.0% in adolescence-onset ESRD (onset at ages 12–21), and 1.7% in child-onset ESRD (onset at ages 1–11 years). The 1-year CVD hospitalization rate (138/1000 patient-years) in the young-adulthood group was higher than in the childhood or adolescence gr…

Reviewing Author

Karol E. Watson, MD, PhD, FACC

Disclosures

Consultant/Advisory BoardBoehringer Ingelheim; Amgen; Novartis; Lilly; Amarin

Speaker’s BureauBoehringer Ingelheim

Grant/Research SupportNIH

Editorial BoardsCirculation (Associate Editor)